Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of May 20, 2024
Click Here to Manage Email Alerts
In this edition, difficult-to-treat psoriatic arthritis 'not all about the therapies', Samsung biosimilar comparable to etanercept and more.
Read the full coverage here:
Difficult-to-treat psoriatic arthritis 'not all about the therapies'
Samsung biosimilar comparable to etanercept for psoriatic arthritis outcomes at 1 year
Boehringer Ingelheim, Quallent partner to expand Humira biosimilar access
VIDEO: Mitigating risk for psoriatic arthritis in patients with psoriasis
FDA approves high-concentration, citrate-free form of interchangeable biosimilar Cyltezo
References:
Healio Interview
Łosińska K, et al. Arthritis Care Res. 2024;doi:10.1002/acr.25345.
Ogdie-Beatty A. Psoriatic Arthritis in 2024. Presented at The Congress of Clinical Rheumatology East; May 9-12, 2024; Destin, Florida (hybrid meeting).
Collapse
Read more about
Click Here to Manage Email Alerts
